Wegovy vs Zepbound at a Glance
| Attribute | Wegovy | Zepbound |
|---|---|---|
| Drug class | GLP-1 agonist | GLP-1 / GIP dual agonist |
| Active ingredient | Semaglutide 2.4 mg | Tirzepatide 5-15 mg |
| Avg weight loss (68 wks) | ~14.9% body weight | ~20.9% body weight |
| List price | $1,349/mo | $1,086/mo |
| Common side effects | Nausea, constipation | Nausea, diarrhea, fatigue |
| Best for | Established GLP-1 history | Maximum weight loss |
Wegovy (semaglutide) and Zepbound (tirzepatide) are both FDA-approved weekly weight-loss injections, but they differ in mechanism and trial results. Wegovy is a single GLP-1 agonist averaging 15% body-weight loss at 68 weeks. Zepbound is a dual GIP/GLP-1 agonist averaging 20-22% body-weight loss at 72 weeks. In 2026, both list at $1,000-$1,350 monthly cash, $0-$50 with covered insurance, and roughly $300-$500 monthly when accessed through compounded telehealth programs where legally available.
When choosing a GLP-1 weight loss injection, two medications dominate the market: Wegovy (semaglutide) and Zepbound (tirzepatide). Both have shown remarkable results in clinical trials, but they work differently and offer distinct advantages. Here’s a comprehensive comparison to help you decide.
Medication Overview
Wegovy (Semaglutide): Single-Target GLP-1
Wegovy is a GLP-1 receptor agonist that works by:
- Slowing gastric emptying to increase satiety
- Reducing appetite through brain signaling
- Improving insulin sensitivity for better blood sugar control
- Weekly injection for consistent effects
Zepbound (Tirzepatide): Dual-Target GLP-1/GIP
Zepbound is a dual GLP-1 and GIP receptor agonist that provides:
- Enhanced appetite suppression through dual hormone targeting
- Superior weight loss results compared to single-target medications
- Improved metabolic effects beyond weight loss
- Weekly injection with potentially stronger effects
Cost Comparison
| Medication | Monthly Cost | Insurance Coverage | Features |
|---|---|---|---|
| Wegovy | $1,300-1,400/month | Limited coverage | Single GLP-1 targeting |
| Zepbound | $1,060/month | Limited coverage | Dual GLP-1/GIP targeting |
Effectiveness
Both medications have shown impressive results in clinical trials:
- Wegovy users achieve average weight loss of 15% over 68 weeks
- Zepbound users achieve average weight loss of 20-25% over 72 weeks
- Clinical studies show Zepbound provides superior weight loss results
Which Medication is Right for You?
Choose Wegovy if you:
- Want a proven, FDA-approved GLP-1 medication
- Prefer a single-target approach with established safety profile
- Have insurance coverage or can afford higher costs
- Want to start with a well-studied medication
Choose Zepbound if you:
- Want maximum weight loss results
- Are willing to try a newer dual-target medication
- Can afford the cost (slightly lower than Wegovy)
- Want the most advanced GLP-1 technology available
Final Verdict
Both medications are highly effective for weight loss, but Zepbound offers superior results in clinical trials. The choice depends on your weight loss goals, budget, and preference for established vs. cutting-edge treatments. Both require medical supervision and lifestyle changes for optimal results.
Health Disclaimer: BestMedsHub is not a healthcare provider, telehealth service, pharmacy, or medical organization. We do not prescribe medication, diagnose conditions, render medical opinions, or facilitate clinical consultations. All content is for general informational and comparison purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified physician, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any treatment, medication, supplement, or health program. Never disregard professional medical advice or delay seeking it because of anything you have read on this site. If you think you may have a medical emergency, call your local emergency number immediately.
FDA & Prescription Medication Disclaimer: Prescription medications referenced on this page are available only through a licensed healthcare provider after a clinical evaluation, and may not be appropriate or safe for everyone. Any statements regarding dietary supplements, wellness products, or off-label uses have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary and are not guaranteed. Always read the medication guide and consult your prescriber and pharmacist about side effects, contraindications, and drug interactions.
